CEO of growing Peninsula biotech steps down in wake of FDA approval, big Pfizer deal
January 04, 2021 at 14:24 PM EST
The sudden CEO switch comes as the company preps for the launch of its prostate cancer drug, seeks FDA approval of a treatment for heavy menstrual bleeding and looks to cut deals to beef up its drug portfolio.
